Skip to main content

Advertisement

SpringerLink
Log in

Sublingual (SLIT) Versus Oral Immunotherapy (OIT) for Food Allergy

  • IMMUNOTHERAPY AND IMMUNOMODULATORS (L COX, SECTION EDITOR)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Food allergy is a common condition for which the only currently approved treatments are avoidance of the allergenic food and the administration of emergency medications upon accidental exposure. Over the past 10 years, significant advances have been made in the field of food immunotherapy, with efforts focusing on allergen exposure via the oral mucosa. Oral immunotherapy (OIT) and sublingual immunotherapy (SLIT) are the two modalities that have been most extensively studied, and this article will review recent advances in our knowledge of the efficacy and safety of these treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Sicherer SH. Epidemiology of food allergy. J Allergy Clin Immunol. 2011;127:594–602.

    Article  PubMed  Google Scholar 

  2. Sicherer SH, Munoz-Furlong A, Godbold JH, Sampson HA. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol. 2010;125:1322–6.

    Article  CAS  PubMed  Google Scholar 

  3. Venter C, Hasan Arshad S, Grundy J, et al. Time trends in the prevalence of peanut allergy: three cohorts of children from the same geographical location in the UK. Allergy. 2010;65:103–8.

    Article  CAS  PubMed  Google Scholar 

  4. Savage JH, Limb SL, Brereton NH, Wood RA. The natural history of peanut allergy: extending our knowledge beyond childhood. J Allergy Clin Immunol. 2007;120:717–9.

    Article  PubMed  Google Scholar 

  5. Savage JH, Matsui EC, Skripak JM, Wood RA. The natural history of egg allergy. J Allergy Clin Immunol. 2007;120:1413–7.

    Article  CAS  PubMed  Google Scholar 

  6. Skolnick HS, Conover-Walker MK, Koerner CB, Sampson HA, Burks W, Wood RA. The natural history of peanut allergy. J Allergy Clin Immunol. 2001;107:367–74.

    Article  CAS  PubMed  Google Scholar 

  7. Fleischer DM, Perry TT, Atkins D, et al. Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics. 2012;130:e25–32.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Yu JW, Kagan R, Verreault N, et al. Accidental ingestions in children with peanut allergy. J Allergy Clin Immunol. 2006;118:466–72.

    Article  PubMed  Google Scholar 

  9. Flokstra-de Blok BM, Dubois AE, Vlieg-Boerstra BJ, et al. Health-related quality of life of food allergic patients: comparison with the general population and other diseases. Allergy. 2010;65:238–44.

    Article  CAS  PubMed  Google Scholar 

  10. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol. 2014;133:621–31.

    Article  CAS  PubMed  Google Scholar 

  11. Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DY. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol. 1992;90:256–62.

    Article  CAS  PubMed  Google Scholar 

  12. Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol. 1997;99:744–51.

    Article  CAS  PubMed  Google Scholar 

  13. Vickery BP, Scurlock AM, Jones SM, Burks AW. Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol. 2011;127:576–84. quiz 85–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Patriarca G, Schiavino D, Nucera E, Schinco G, Milani A, Gasbarrini GB. Food allergy in children: results of a standardized protocol for oral desensitization. Hepato-Gastroenterology. 1998;45:52–8.

    CAS  PubMed  Google Scholar 

  15. Meglio P, Bartone E, Plantamura M, Arabito E, Giampietro PG. A protocol for oral desensitization in children with IgE-mediated cow’s milk allergy. Allergy. 2004;59:980–7.

    Article  CAS  PubMed  Google Scholar 

  16. Longo G, Barbi E, Berti I, et al. Specific oral tolerance induction in children with very severe cow’s milk-induced reactions. J Allergy Clin Immunol. 2008;121:343–7.

    Article  CAS  PubMed  Google Scholar 

  17. Skripak JM, Nash SD, Rowley H, et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow’s milk allergy. J Allergy Clin Immunol. 2008;122:1154–60.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Pajno GB, Caminiti L, Ruggeri P, et al. Oral immunotherapy for cow’s milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2010;105:376–81.

    Article  CAS  Google Scholar 

  19. Martorell A, De la Hoz B, Ibanez MD, et al. Oral desensitization as a useful treatment in 2-year-old children with cow’s milk allergy. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2011;41:1297–304.

    Article  CAS  Google Scholar 

  20. Garcia-Ara C, Pedrosa M, Belver MT, Martin-Munoz MF, Quirce S, Boyano-Martinez T. Efficacy and safety of oral desensitization in children with cow’s milk allergy according to their serum specific IgE level. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2013;110:290–4.

    Article  CAS  Google Scholar 

  21. Salmivesi S, Korppi M, Makela MJ, Paassilta M. Milk oral immunotherapy is effective in school-aged children. Acta Paediatr (Oslo, Norway : 1992). 2013;102:172–6.

    Article  Google Scholar 

  22. Patriarca G, Nucera E, Roncallo C, et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther. 2003;17:459–65.

    Article  CAS  PubMed  Google Scholar 

  23. Morisset M, Moneret-Vautrin DA, Guenard L, et al. Oral desensitization in children with milk and egg allergies obtains recovery in a significant proportion of cases. A randomized study in 60 children with cow’s milk allergy and 90 children with egg allergy. Eur Ann Allergy Clin Immunol. 2007;39:12–9.

    CAS  PubMed  Google Scholar 

  24. Brozek JL, Terracciano L, Hsu J, et al. Oral immunotherapy for IgE-mediated cow’s milk allergy: a systematic review and meta-analysis. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2012;42:363–74.

    Article  CAS  Google Scholar 

  25. Yeung JP, Kloda LA, McDevitt J, Ben-Shoshan M, Alizadehfar R. Oral immunotherapy for milk allergy. Cochrane Database Syst Rev. 2012;11, CD009542. In this systematic review and meta-analysis, the authors concluded that while OIT for milk allergy appears to be efficacious, the quality of evidence is low due to small studies with inconsistent methodology.

    PubMed  Google Scholar 

  26. Meglio P, Giampietro PG, Gianni S, Galli E. Oral desensitization in children with immunoglobulin E-mediated cow’s milk allergy—follow-up at 4 yr and 8 months. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2008;19:412–9.

    Article  Google Scholar 

  27. Keet CA, Seopaul S, Knorr S, Narisety S, Skripak J, Wood RA. Long-term follow-up of oral immunotherapy for cow’s milk allergy. J Allergy Clin Immunol. 2013;132:737–9.e6. In a study examining the long-term efficacy of milk OIT, the authors found that 22% of patients ate only trace amounts of milk/baked milk or avoided milk completely 3–4 years after therapy.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Narisety SD, Skripak JM, Steele P, et al. Open-label maintenance after milk oral immunotherapy for IgE-mediated cow’s milk allergy. J Allergy Clin Immunol. 2009;124:610–2.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, et al. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol. 2012;129:448–55.e1-5. In this randomized controlled trial comparing milk SLIT to OIT, the authors found that those undergoing OIT were more likely to develop desensitization to milk than those undergoing SLIT. Those on OIT, however, were also more likely to have systemic reactions during treatment than those on SLIT.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Buchanan AD, Green TD, Jones SM, et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol. 2007;119:199–205.

    Article  CAS  PubMed  Google Scholar 

  31. Vickery BP, Pons L, Kulis M, Steele P, Jones SM, Burks AW. Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2010;105:444–50.

    Article  CAS  Google Scholar 

  32. Garcia Rodriguez R, Urra JM, Feo-Brito F, et al. Oral rush desensitization to egg: efficacy and safety. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2011;41:1289–96.

    Article  CAS  Google Scholar 

  33. Burks AW, Jones SM, Wood RA, et al. Oral immunotherapy for treatment of egg allergy in children. N Engl J Med. 2012;367:233–43. In a randomized controlled trial comparing egg OIT to placebo, the authors found that egg OIT is efficacious in inducing clinical desensitization, and that efficacy appears to improve with longer duration of treatment.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Meglio P, Giampietro PG, Carello R, Gabriele I, Avitabile S, Galli E. Oral food desensitization in children with IgE-mediated hen’s egg allergy: a new protocol with raw hen’s egg. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2013;24:75–83.

    Article  Google Scholar 

  35. Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW. Successful oral tolerance induction in severe peanut allergy. Allergy. 2009;64:1218–20.

    Article  CAS  PubMed  Google Scholar 

  36. Jones SM, Pons L, Roberts JL, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol. 2009;124(292–300):e1–97.

    Google Scholar 

  37. Varshney P, Jones SM, Scurlock AM, et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol. 2011;127:654–60. In this randomized controlled trial comparing peanut OIT to placebo, the efficacy of treatment for inducing clinical desensitization was 84 %.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Anagnostou K, Islam S, King Y, et al. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet. 2014;383:1297–304. In a randomized controlled crossover trial of peanut OIT, the authors found that active OIT (maintenance dose 800 mg/day) resulted in desensitization in 84–91 % of treated children.

    Article  CAS  PubMed  Google Scholar 

  39. Blumchen K, Ulbricht H, Staden U, et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol. 2010;126:83–91.e1.

    Article  CAS  PubMed  Google Scholar 

  40. Syed A, Garcia MA, Lyu SC, et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol. 2014;133:500–10.

    Article  CAS  PubMed  Google Scholar 

  41. Wasserman RL, Factor JM, Baker JW, et al. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions. J Allergy Clin Immunol Pract. 2014;2:91–6.

    Article  PubMed  Google Scholar 

  42. Anagnostou K, Clark A, King Y, Islam S, Deighton J, Ewan P. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2011;41:1273–81.

    Article  CAS  Google Scholar 

  43. Ridolo E, De Angelis GL, Dall’aglio P. Eosinophilic esophagitis after specific oral tolerance induction for egg protein. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2011;106:73–4.

    Article  Google Scholar 

  44. Sanchez-Garcia S, Rodriguez Del Rio P, Escudero C, Martinez-Gomez MJ, Ibanez MD. Possible eosinophilic esophagitis induced by milk oral immunotherapy. J Allergy Clin Immunol. 2012;129:1155–7.

    Article  PubMed  Google Scholar 

  45. Nadeau KC, Schneider LC, Hoyte L, Borras I, Umetsu DT. Rapid oral desensitization in combination with omalizumab therapy in patients with cow’s milk allergy. J Allergy Clin Immunol. 2011;127:1622–4.

    Article  PubMed Central  PubMed  Google Scholar 

  46. Schneider LC, Rachid R, LeBovidge J, Blood E, Mittal M, Umetsu DT. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients. J Allergy Clin Immunol. 2013;132:1368–74. In this pilot study, children with peanut allergy were treated with both OIT and omalizumab. The authors found that 92 % of patients were desensitized to peanut with this regimen.

    Article  CAS  PubMed  Google Scholar 

  47. Akdis CA, Barlan IB, Bahceciler N, Akdis M. Immunological mechanisms of sublingual immunotherapy. Allergy. 2006;61 Suppl 81:11–4.

    Article  PubMed  Google Scholar 

  48. Untersmayr E, Jensen-Jarolim E. The role of protein digestibility and antacids on food allergy outcomes. J Allergy Clin Immunol. 2008;121:1301–8. quiz 9–10.

    Article  PubMed Central  PubMed  Google Scholar 

  49. de Boissieu D, Dupont C. Sublingual immunotherapy for cow’s milk protein allergy: a preliminary report. Allergy. 2006;61:1238–9.

    Article  PubMed  Google Scholar 

  50. Kim EH, Bird JA, Kulis M, et al. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol. 2011;127:640–6.e1.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  51. Fleischer DM, Burks AW, Vickery BP, et al. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol. 2013;131:119–27.e1-7. In this randomized controlled trial comparing peanut SLIT to placebo, the authors found that peanut SLIT induced a modest level of desensitization in most children, and this efficacy appeared to be related to duration of treatment.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  52. Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol. 2005;116:1073–9.

    Article  CAS  PubMed  Google Scholar 

  53. Fernandez-Rivas M, Garrido Fernandez S, Nadal JA, et al. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy. 2009;64:876–83.

    Article  CAS  PubMed  Google Scholar 

  54. Chin SJ, Vickery BP, Kulis MD, et al. Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. J Allergy Clin Immunol. 2013;132:476–8.e2. In this retrospective study comparing peanut OIT to SLIT, the authors found that OIT was more efficacious than SLIT for inducing clinical desensitization. They also found that those on OIT had greater measures of immunologic desensitization than those on SLIT.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  55. Alvaro M, Giner MT, Vazquez M, et al. Specific oral desensitization in children with IgE-mediated cow’s milk allergy. Evolution in one year. Eur J Pediatr. 2012;171:1389–95.

    Article  CAS  PubMed  Google Scholar 

  56. Levy MB, Elizur A, Goldberg MR, Nachshon L, Katz Y. Clinical predictors for favorable outcomes in an oral immunotherapy program for IgE-mediated cow’s milk allergy. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2014;112:58–63.e1.

    Article  CAS  Google Scholar 

  57. Staden U, Rolinck-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy. 2007;62:1261–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Emily C. McGowan reports no conflict of interest.

Robert A. Wood reports grants from NIH and royalties from Up to Date.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the authors.

Author information

Authors and Affiliations

  1. Division of Allergy and Clinical Immunology, Department of Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Emily C. McGowan

  2. Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Robert A. Wood

  3. Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Emily C. McGowan

Authors
  1. Emily C. McGowan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert A. Wood
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert A. Wood.

Additional information

This article is part of the Topical Collection on Immunotherapy and Immunomodulators

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McGowan, E.C., Wood, R.A. Sublingual (SLIT) Versus Oral Immunotherapy (OIT) for Food Allergy. Curr Allergy Asthma Rep 14, 486 (2014). https://doi.org/10.1007/s11882-014-0486-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-014-0486-9

Keywords

Search

Navigation